Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

6-((3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy)-N-methyl-3-pyridinecarboxamide MeSH Supplementary Concept Data 2025


MeSH Supplementary
6-((3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy)-N-methyl-3-pyridinecarboxamide
Unique ID
C521312
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C521312
Entry Term(s)
GSK 189254
GSK-189254
GSK189254
Registry Numbers
5T4TX6CO53
Heading Mapped to
*Benzazepines
Niacinamide / analogs & derivatives
Frequency
26
Note
GSK-189254 is the HCl salt; an H3 receptor antagonist; putative cognitive enhancer; structure in first source
Source
J Pharmacol Exp Ther 2007 Jun;321(3):1032-45
Indexing Information
Receptors, Histamine H3
Date of Entry
2007/07/23
Revision Date
2019/01/07
6-((3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy)-N-methyl-3-pyridinecarboxamide Preferred
GSK 189254 Narrower
page delivered in 0.008s